블로그
- Ponceau 4R (Standard) [TMSM-1927][Cas No. 2611-82-7]_TargetMol - 코아사이언스 be used for human consumption. Please comply with the intended use and do not use TargetMol products for any other purpose.
- Erythrosine B (Standard) [TMSM-1065][Cas No. 16423-68-0]_TargetMol - 코아사이언스 be used for human consumption. Please comply with the intended use and do not use TargetMol products for any other purpose.
- Amaranth (Standard) [TMSM-0409][Cas No. 915-67-3]_TargetMol - 코아사이언스 be used for human consumption. Please comply with the intended use and do not use TargetMol products for any other purpose.
- Tartrazine (Standard) [TMSM-2186][Cas No. 1934-21-0]_TargetMol - 코아사이언스 be used for human consumption. Please comply with the intended use and do not use TargetMol products for any other purpose.
- [식약처] 건강기능식품 기능성 원료 및 기준 규격 인정에 관한 규정(고시 제2026-33호)_영문번역본 seq=33724&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq =0&c.......
- Lean On You | Official Music Video by Shalena J-Vocals: AI-Generated Lord, while You piece my puzzle together, I keep reaching for the view... ✍️ Lyrics & Melody by Shalena J | Music & Vocals: AI-Generated Loving Me Loving Me AI Lo.......
- Beneath the S&P 500 rally: Where performance and fundamentals diverge disconnecting from underlying fundamentals, Barclays analysts said, as investors chase upside and demand for The S&P 500 is up 13.1% year-to-date, compared with a 17.9% gain for the Nasdaq and a 21% rise for
- Clozapine [T0455][Cas No. 5786-21-0]_TargetMol - 코아사이언스 only and cannot be used for human consumption. Bioactivity Chemical Properties Storage & Solubility References 1.Robertson GS, et al.
- AI로 그려본 Outdoor Wearable Exoskeleton Suits for the elderly (2008) - Dancing Queen Scene (3/10) | Movieclips Turn It Into Love - Wink (교차편집) Joanna - Cool & The Gang Especially For You - Wink
- Beneath the S&P 500 rally: Where performance and fundamentals diverge disconnecting from underlying fundamentals, Barclays analysts said, as investors chase upside and demand for The S&P 500 is up 13.1% year-to-date, compared with a 17.9% gain for the Nasdaq and a 21% rise for